Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath Publishes Summer 2026 Issue of Alumni Journal

Read More

News & Insights

Teradata Corporation’s Credit Facilities

July 14, 2022

Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with the arrangement of $900 million of credit facilities made available to Teradata Corporation, a software company that provides a connected multi‑cloud data platform for enterprise analytics. The facilities consisted of a $500 million term loan facility and a $400 million revolving credit facility. The transaction closed on June 28, 2022.

The Cravath team included partner Tatiana Lapushchik and associate Trevor Lutzow on banking matters and partner Arvind Ravichandran on tax matters. Michael Pelle also worked on tax matters and summer associate Emily Gust also worked on banking matters.

Related Practices & Industries

  • Corporate
  • Banking and Credit
  • Tax
  • Technology

People

Photo
Name
Tatiana Lapushchik
Title
Corporate
Title
Partner
Email
tlapushchik@cravath.com
Phone
+1-212-474-1442
vCard
Download vCard

    Education

    • J.D., 2000, Harvard Law School
      cum laude
    • B.A., 1997, Barnard College
      summa cum laude

    Admitted In

    • New York
    Photo
    Name
    Arvind Ravichandran
    Title
    Tax
    Title
    Partner
    Email
    aravichandran@cravath.com
    Phone
    +1-212-474-1033
    vCard
    Download vCard

      Education

      • J.D., 2012, Columbia Law School
      • B.A., 2009, Columbia College

      Admitted In

      • New York

      Related News & Insights

      Deals & Cases

      July 13, 2026

      Boluda Towage’s €2.45 Billion Term Loan and Revolving Credit Facilities 

      Cravath represented the agent, mandated lead arrangers and lenders in connection with Boluda Towage’s €2.15 billion (equivalent) term loan facility and €300 million multi‑currency revolving credit facility. The proceeds will be used towards refinancing certain existing credit facilities and for general corporate purposes. Boluda Towage is a leading maritime services operator. The transaction closed on June 30, 2026. 

      Deals & Cases

      April 06, 2026

      Versigent’s $1.35 Billion Credit Facilities and $1.6 Billion High‑Yield Senior Notes Offering in Connection with Aptiv PLC’s Spin‑Off of Versigent

      Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.

      Deals & Cases

      February 20, 2026

      First Solar’s $1.5 Billion Revolving Credit Facility

      Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.

      Deals & Cases

      January 08, 2026

      Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus

      Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.

      Cravath Bicentennial

      Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

      Explore

      Cravath, Swaine & Moore LLP Logo
      • CONTACT US
      • OUR STORY
      • ALUMNI PORTAL
      • DISCLAIMERS & NOTICES

      Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.